{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:52:55Z","timestamp":1793829175600,"version":"4.6.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T00:00:00Z","timestamp":1498608000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s10072-017-3043-1","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T14:28:10Z","timestamp":1498660090000},"page":"1665-1669","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Serum uric acid concentrations are directly associated with the presence of benign multiple sclerosis"],"prefix":"10.1007","volume":"38","author":[{"given":"Esteban","family":"Simental-Mend\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3617-4921","authenticated-orcid":false,"given":"Luis E.","family":"Simental-Mend\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Guerrero-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,28]]},"reference":[{"issue":"3","key":"3043_CR1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(08)70042-5","volume":"7","author":"GC Ebers","year":"2008","unstructured":"Ebers GC (2008) Environmental factors and multiple sclerosis. Lancet Neurol 7(3):268\u2013277","journal-title":"Lancet Neurol"},{"issue":"3","key":"3043_CR2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10072-016-2802-8","volume":"38","author":"J Zostawa","year":"2017","unstructured":"Zostawa J, Adamczyk J, Sowa P, Adamczyk-Sowa M (2017) The influence of sodium on pathophysiology of multiple sclerosis. Neurol Sci 38(3):389\u2013398","journal-title":"Neurol Sci"},{"issue":"3","key":"3043_CR3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0165-5728(83)90036-X","volume":"4","author":"U Traugott","year":"1983","unstructured":"Traugott U, Reinherz EL, Raine CS (1983) Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages. J Neuroimmunol 4(3):201\u2013221","journal-title":"J Neuroimmunol"},{"issue":"Suppl","key":"3043_CR4","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1002\/ana.410360716","volume":"36","author":"CS Raine","year":"1994","unstructured":"Raine CS (1994) The Dale E. McFarlin memorial lecture: the immunology of the multiple sclerosis lesion. Ann Neurol 36(Suppl):S61\u2013S72","journal-title":"Ann Neurol"},{"issue":"13","key":"3043_CR5","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","volume":"343","author":"JH Noseworthy","year":"2000","unstructured":"Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343(13):938\u2013952","journal-title":"N Engl J Med"},{"issue":"2","key":"3043_CR6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1179\/1743132811Y.0000000074","volume":"34","author":"B Liu","year":"2012","unstructured":"Liu B, Shen Y, Xiao K, Tang Y, Cen L, Wei J (2012) Serum uric acid levels in patients with multiple sclerosis: a meta-analysis. Neurol Res 34(2):163\u2013171","journal-title":"Neurol Res"},{"key":"3043_CR7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.msard.2016.05.008","volume":"9","author":"L Wang","year":"2016","unstructured":"Wang L, Hu W, Wang J, Qian W, Xiao H (2016) Low serum uric acid levels in patients with multiple sclerosis and neuromyelitis optica: an updated meta-analysis. Mult Scler Relat Disord 9:17\u201322","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"3043_CR8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10072-011-0488-5","volume":"32","author":"AL Guerrero","year":"2011","unstructured":"Guerrero AL, Guti\u00e9rrez F, Iglesias F, Mart\u00edn-Polo J, Merino S, Mart\u00edn-Serradilla JI, Laherr\u00e1n E, Tejero MA (2011) Serum uric acid levels in multiple sclerosis patients inversely correlate with disability. Neurol Sci 32(2):347\u2013350","journal-title":"Neurol Sci"},{"issue":"5","key":"3043_CR9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1532-5415.1993.tb01885.x","volume":"41","author":"JK Maesaka","year":"1993","unstructured":"Maesaka JK, Wolf-Klein G, Piccione JM, Ma CM (1993) Hypouricemia, abnormal renal tubular urate transport, and plasma natriuretic factor(s) in patients with Alzheimer\u2019s disease. J Am Geriatr Soc 41(5):501\u2013506","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"3043_CR10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1468-1331.2002.00384.x","volume":"9","author":"G Toncev","year":"2002","unstructured":"Toncev G, Milicic B, Toncev S, Samardzic G (2002) Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction. Eur J Neurol 9(3):221\u2013226","journal-title":"Eur J Neurol"},{"key":"3043_CR11","first-page":"80","volume":"13","author":"T Kalnovi\u010dov\u00e1","year":"2009","unstructured":"Kalnovi\u010dov\u00e1 T, Tur\u010d\u00e1ni P (2009) Plasma uric acid levels in multiple sclerosis patients as a marker of disease activity and blood\u2013brain barrier dysfunction. Psychiatrie 13:80\u201381","journal-title":"Psychiatrie"},{"issue":"2","key":"3043_CR12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302","journal-title":"Ann Neurol"},{"issue":"7","key":"3043_CR13","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/01.wnl.0000253185.03943.66","volume":"68","author":"AL Sayao","year":"2007","unstructured":"Sayao AL, Devonshire V, Tremlett H (2007) Longitudinal follow-up of \u201cbenign\u201d multiple sclerosis at 20 years. Neurology 68(7):496\u2013500","journal-title":"Neurology"},{"issue":"3","key":"3043_CR14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/WCO.0000000000000206","volume":"28","author":"I Katz Sand","year":"2015","unstructured":"Katz Sand I (2015) Classification, diagnosis, and differential diagnosis of multiple sclerosis. Curr Opin Neurol 28(3):193\u2013205","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"3043_CR15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s100720200059","volume":"23","author":"S Sotgiu","year":"2002","unstructured":"Sotgiu S, Pugliatti M, Sanna A, Sotgiu A, Fois ML, Arru G, Rosati G (2002) Serum uric acid and multiple sclerosis. Neurol Sci 23(4):183\u2013188","journal-title":"Neurol Sci"},{"issue":"2","key":"3043_CR16","first-page":"109","volume":"2","author":"P Fang","year":"2013","unstructured":"Fang P, Li X, Luo JJ, Wang H, Yang XF (2013) A double-edged sword: uric acid and neurological disorders. Brain Disord Ther 2(2):109","journal-title":"Brain Disord Ther"},{"issue":"2","key":"3043_CR17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s004150170246","volume":"248","author":"J Drulovi\u0107","year":"2001","unstructured":"Drulovi\u0107 J, Dujmovi\u0107 I, Stojsavljevi\u0107 N, Mesaros S, Andjelkovi\u0107 S, Miljkovi\u0107 D, Peri\u0107 V, Dragutinovi\u0107 G, Marinkovi\u0107 J, Levi\u0107 Z, Mostarica Stojkovi\u0107 M (2001) Uric acid levels in sera from patients with multiple sclerosis. J Neurol 248(2):121\u2013126","journal-title":"J Neurol"},{"issue":"1","key":"3043_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(97)00013-1","volume":"77","author":"RC Veen van der","year":"1997","unstructured":"van der Veen RC, Hinton DR, Incardonna F, Hofman FM (1997) Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J Neuroimmunol 77(1):1\u20137","journal-title":"J Neuroimmunol"},{"issue":"7","key":"3043_CR19","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1468-1331.2005.01009.x","volume":"12","author":"GS Ramsaransing","year":"2005","unstructured":"Ramsaransing GS, Heersema DJ, De Keyser J (2005) Serum uric acid, dehydroepiandrosterone sulphate, and apolipoprotein E genotype in benign vs. progressive multiple sclerosis. Eur J Neurol 12(7):514\u2013518","journal-title":"Eur J Neurol"},{"issue":"6","key":"3043_CR20","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1073\/pnas.94.6.2528","volume":"94","author":"DC Hooper","year":"1997","unstructured":"Hooper DC, Bagasra O, Marini JC, Zborek A, Ohnishi ST, Kean R, Champion JM, Sarker AB, Bobroski L, Farber JL, Akaike T, Maeda H, Koprowski H (1997) Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci U S A 94(6):2528\u20132533","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3043_CR21","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1073\/pnas.95.2.675","volume":"95","author":"DC Hooper","year":"1998","unstructured":"Hooper DC, Spitsin S, Kean RB, Champion JM, Dickson GM, Chaudhry I, Koprowski H (1998) Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A 95(2):675\u2013680","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3043_CR22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/135245850100700507","volume":"7","author":"S Spitsin","year":"2001","unstructured":"Spitsin S, Hooper DC, Leist T, Streletz LJ, Mikheeva T, Koprowskil H (2001) Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease. Mult Scler 7(5):313\u2013319","journal-title":"Mult Scler"},{"issue":"6","key":"3043_CR23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/135245850000600603","volume":"6","author":"CS Constantinescu","year":"2000","unstructured":"Constantinescu CS, Freitag P, Kappos L (2000) Increase in serum levels of uric acid, an endogenous antioxidant, under treatment with glatiramer acetate for multiple sclerosis. Mult Scler 6(6):378\u2013381","journal-title":"Mult Scler"},{"issue":"18","key":"3043_CR24","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/WNL.0000000000000376","volume":"82","author":"VM Rivera","year":"2014","unstructured":"Rivera VM, Medina MT, Duron RM, Macias MA (2014) Multiple sclerosis care in Latin America. Neurology 82(18):1660\u20131661","journal-title":"Neurology"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-017-3043-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-3043-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-3043-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T09:16:40Z","timestamp":1569575800000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-017-3043-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,28]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["3043"],"URL":"https:\/\/doi.org\/10.1007\/s10072-017-3043-1","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,28]]}}}